Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

MIXED(1)
1 unique interventions1 categories

Analytics

Trial Phases

Phase 21

Trial Status

Terminated1

Role Distribution

Principal Investigator1
PI Rate100%

Activity Timeline

Clinical Trials (1)

NCT04317781Phase 2Terminated
Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant
Blastic Plasmacytoid Dendritic Cell Neoplasm
PrincipalinvestigatorStart date: 2020-03-27

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

M.D. Anderson Cancer Center

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Abhishek Maiti, MBBS

M.D. Anderson Cancer Center

Moderately Similar
3 trials

Shared therapeutic areas:

Blastic Plasmacytoid Dendritic Cell Neoplasm

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score30%

Seokjin Kim, M.D., PhD

Samsung Medical Center

Moderately Similar
1 trials

Shared therapeutic areas:

Blastic Plasmacytoid Dendritic Cell Neoplasm
Similarity Score30%

Gevorg Tamamyan, MD, PhD, DSc

Immune Oncology Research Institute, Yerevan, Armenia

Moderately Similar
2 trials

Shared therapeutic areas:

Blastic Plasmacytoid Dendritic Cell Neoplasm
Similarity Score30%

Swati Naik, MD

St. Jude Children's Research Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Blastic Plasmacytoid Dendritic Cell Neoplasm
Similarity Score30%

Jia Wei, M.D

Shanxi Bethune Hospital

Moderately Similar
1 trials

Shared therapeutic areas:

Blastic Plasmacytoid Dendritic Cell Neoplasm
Similarity Score30%

Jan Vydra, MD, PhD

Institute of Hematology and Blood Transfusion, Prague, Czech Republic

Moderately Similar
1 trials

Shared therapeutic areas:

Blastic Plasmacytoid Dendritic Cell Neoplasm
Similarity Score30%

Maryam Fouladi

COG Phase I Consortium

Moderately Similar
1 trials

Shared therapeutic areas:

Blastic Plasmacytoid Dendritic Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Raman Garcha, MD

Xencor, Inc.

Moderately Similar
1 trials

Shared therapeutic areas:

Blastic Plasmacytoid Dendritic Cell Neoplasm
Similarity Score30%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Moderately Similar
11 trials

Shared therapeutic areas:

Blastic Plasmacytoid Dendritic Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Marie Bleakley

Fred Hutch/University of Washington Cancer Consortium

Moderately Similar
4 trials

Shared therapeutic areas:

Blastic Plasmacytoid Dendritic Cell Neoplasm

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score30%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT04317781Phase 2PrincipalInvestigator

Tagraxofusp in Treating Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm After Stem Cell Transplant

Blastic Plasmacytoid Dendritic Cell Neoplasm
Terminated

All 1 trials loaded